SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
RANDOMIZED TRIAL OF RALTEGRAVIR-ART VS EFAVIRENZ-ART WHEN INITIATED DURING PREGNANCY (ABSTRACT
39)
Mark Mirochnick
Boston University School of Medicine, Hingham, MA, USA
RCT OF DOLUTEGRAVIR VS EFAVIRENZ-BASED THERAPY INITIATED IN LATE PREGNANCY: DOLPHIN-2 (ABSTRACT
40)
Saye Khoo
University of Liverpool Institute of Translational Medicine, Liverpool, United Kingdom
MATERNAL HBV VIREMIA IS ASSOCIATED WITH ADVERSE INFANT OUTCOMES IN HIV/HBV WOMEN (ABSTRACT
41)
Debika Bhattacharya
University of California Los Angeles, Los Angeles, CA, USA
IMPACT OF IMPROVED NUTRITION/SANITATION ON NEURODEVELOPMENT OF HIV-EXPOSED CHILDREN (ABSTRACT
42)
Robert Ntozini
Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe
UNIQUE IMMUNOLOGICAL AND VIROLOGICAL FEATURES OF EARLY TREATED HIV-INFECTED NEWBORNS (ABSTRACT
43)
Pilar Garcia Broncano
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
NEONATAL ART < 7 DAYS VS 7-28 DAYS REDUCED TIME TO SUPPRESSION (ABSTRACT
44)
Sara Dominguez Rodriguez
Fundación Investigación Biomédica Hospital 12 Octubre, Madrid, Spain
SAFETY AND PHARMACOKINETICS OF MONOCLONAL ANTIBODY, VRC01LS, IN HIV-EXPOSED NEWBORNS (ABSTRACT
45)
Elizabeth J McFarland
University of Colorado School of Medicine, Aurora, CO, USA
BICTEGRAVIR/FTC/TAF SINGLE-TABLET REGIMEN IN ADOLESCENTS & CHILDREN: WEEK 48 RESULTS (ABSTRACT
46)
Aditya Gaur
St. Jude Children's Research Hospital, Memphis, TN, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
